aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIFE aTyr Pharma

Trading 11-22 09:46:07 EST

1.90

+0.00

0.00%

High1.90	Low1.90	Vol0.00
Open1.90	D1 Closing1.90	Amplitude0.00%
Mkt Cap131.12M	Tradable Cap127.63M	Total Shares69.01M
T/O506.87K	T/O Rate0.00%	Tradable Shares67.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LIFE","market":"US","secType":"STK","nameCN":"aTyr Pharma","latestPrice":1.9,"timestamp":1717531200000,"preClose":1.9,"halted":8,"volume":0,"delay":0,"floatShares":67173358,"shares":69010940,"eps":-0.904057,"marketStatus":"Trading","change":0,"latestTime":"11-22 09:46:07 EST","open":1.9,"high":1.9,"low":1.9,"amount":506865.2986371,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.904057,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1732309200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"ATYR","executeDate":"2024-06-05"},"adr":0,"adrRate":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":1.9,"volumeRatio":0},"requestUrl":"/m/hq/s/LIFE","defaultTab":"news","newsList":[{"id":"2441172786","title":"News On aTyr Pharma Inc. (LIFE) Now Under ATYR","url":"https://stock-news.laohu8.com/highlight/detail?id=2441172786","media":"DowjonesLive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441172786?lang=en_us&edition=fundamental","pubTime":"2024-06-06 05:08","pubTimestamp":1717621680,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"dowjones_live","symbols":["LIFE","BK4139","ATYR","BK4563"],"gpt_icon":0},{"id":"2441200892","title":"Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2441200892","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441200892?lang=en_us&edition=fundamental","pubTime":"2024-06-06 03:17","pubTimestamp":1717615020,"startTime":"0","endTime":"0","summary":"These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/06/millionaire-makers-7-stocks-you-can-buy-for-2-that-can-10x-by-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["BK4173","BK4156","ADIL","LIFE","BK4563","RELI","MNQmain","BK4139","PSQ","BLRX","BK4007","NQmain","TQQQ","EVA","QLD","SOPA","SQQQ","BK4165","KSCP","QQQ",".IXIC","BK4077","QID"],"gpt_icon":1},{"id":"2441224296","title":"Timothy Coughlin Bought 833% More Shares In aTyr Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2441224296","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441224296?lang=en_us&edition=fundamental","pubTime":"2024-06-05 18:31","pubTimestamp":1717583469,"startTime":"0","endTime":"0","summary":"Whilst it may not be a huge deal, we thought it was good to see that the aTyr Pharma, Inc.  Independent Chairman of the Board, Timothy Coughlin, recently bought US$88k worth of stock, for US$1.75 per share. Even though that isn't a massive buy, it did increase their holding by 833%, which is arguably a good sign.aTyr Pharma Insider Transactions Over The Last Year. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/timothy-coughlin-bought-833-more-103109363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4139","LIFE"],"gpt_icon":0},{"id":"2440385498","title":"aTyr Pharma announces Nasdaq ticker symbol change to “ATYR”","url":"https://stock-news.laohu8.com/highlight/detail?id=2440385498","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2440385498?lang=en_us&edition=fundamental","pubTime":"2024-06-03 20:19","pubTimestamp":1717417149,"startTime":"0","endTime":"0","summary":"aTyr Pharma  has announced that the Co. will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Co.’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.”  “As we advance our lead therapeutic candidate, efzofitimod, through a pivotal Phase 3 study in pulmonary sarcoidosis and prepare for potential commercialization, the “ATYR” ticker symbol is a strong reflection of our corporate identity and serves to clarify and enhance our visibility across a broad range of stakeholders,” said Sanjay S. Shukla, M.D., M.S., President and CEO.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4112277-atyr-pharma-announces-nasdaq-ticker-symbol-change-to-atyr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4563","PSQ","NDAQ","BK4112","NQmain","TQQQ","BK4139",".IXIC","SQQQ","QID","MNQmain","QQQ","BK4585","LU2095319765.USD","LU2210150020.SGD","LIFE","QLD","BK4588","LU2210149790.SGD"],"gpt_icon":0},{"id":"2440462552","title":"aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”","url":"https://stock-news.laohu8.com/highlight/detail?id=2440462552","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2440462552?lang=en_us&edition=fundamental","pubTime":"2024-06-03 20:00","pubTimestamp":1717416000,"startTime":"0","endTime":"0","summary":"Ticker symbol change to take effect on Wednesday, June 5, 2024SAN DIEGO, June  03, 2024  (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/03/2892167/0/en/aTyr-Pharma-Announces-Nasdaq-Stock-Ticker-Symbol-Change-from-LIFE-to-ATYR.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","NDAQ","BK4588","LU2095319765.USD","BK4112","LU2210150020.SGD",".IXIC","BK4139","BK4585","LU2210149790.SGD","LIFE"],"gpt_icon":0},{"id":"2439698508","title":"aTyr Pharma Stockholders Endorse Leadership and Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2439698508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2439698508?lang=en_us&edition=fundamental","pubTime":"2024-05-30 15:13","pubTimestamp":1717053193,"startTime":"0","endTime":"0","summary":"aTyr Pharma (LIFE) has shared an update. At the Company’s Annual Meeting, stockholders cast their votes on several key proposals, including the ele...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atyr-pharma-stockholders-endorse-leadership-and-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atyr-pharma-stockholders-endorse-leadership-and-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2065732104.USD","PRGS","BK4563","BK4097","LIFE"],"gpt_icon":0},{"id":"2439528767","title":"aTyr Pharma Buy Rating: Novel Treatment’s Market Potential and Financial Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2439528767","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2439528767?lang=en_us&edition=fundamental","pubTime":"2024-05-29 19:45","pubTimestamp":1716983133,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on LIFE stock, giving a Buy rating on May 14. Soumit Roy has given his Buy rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/atyr-pharma-buy-rating-novel-treatments-market-potential-and-financial-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/atyr-pharma-buy-rating-novel-treatments-market-potential-and-financial-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","LIFE","BK4139"],"gpt_icon":0},{"id":"2438060142","title":"aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2438060142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2438060142?lang=en_us&edition=fundamental","pubTime":"2024-05-25 04:00","pubTimestamp":1716580800,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May  24, 2024  (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-cl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/24/2888158/0/en/aTyr-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ",".IXIC","LU2210150020.SGD","BK4588","LIFE","BK4139","LU2210149790.SGD","LU2095319765.USD","BK4112","BK4563","BK4585"],"gpt_icon":0},{"id":"2437524127","title":"THE SUITE LIFE: CELEBRITY CRUISES ELEVATES 'THE RETREAT' EXPERIENCE","url":"https://stock-news.laohu8.com/highlight/detail?id=2437524127","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2437524127?lang=en_us&edition=fundamental","pubTime":"2024-05-23 21:00","pubTimestamp":1716469200,"startTime":"0","endTime":"0","summary":"With enhanced offerings and new personalized amenities, The Retreat delivers the most elevated experience at sea. MIAMI, May 23, 2024 /PRNewswire/ -- Celebrity Cruises takes the suite life to new heights with new premium and personalized enhancements for The Retreat, providing the most elevated experience at sea. Offering more perks and amenities than ever before, The Retreat isn't just a suite. It's the most elevated experience at sea, period.Culinary enhancements have been added to the offerings at Luminae, the exclusive suites-only restaurant, including new Daniel Boulud Signature dishes and a new rotating dinner and dessert menu. In-suite, guests can enjoy personalized daily delights, selected from the in-suite dining menu, as well as a complimentary stocked minibar.Breakfast, lunch and dinner from the comfort of their suite, selected from the in-suite dining menu, available daily.Complimentary SEA Thermal Suite access on Edge Ser","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4STluaSwUEpr3XhBqVB6uQ--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c7cd7d3c54a517af9a71aa096d196740","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4STluaSwUEpr3XhBqVB6uQ--~B/aD0yNjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c7cd7d3c54a517af9a71aa096d196740"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/suite-life-celebrity-cruises-elevates-130000077.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/suite-life-celebrity-cruises-elevates-130000077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","RCL","BK4585","BK4142","BK4517","BK4566","BK4588","LIFE","BK4563"],"gpt_icon":0},{"id":"2437328794","title":"SWISS LIFE HOLDING AG :Swiss Life Increases Fee Income By 11% In The First Quarter Of 2024.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437328794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2437328794?lang=en_us&edition=fundamental","pubTime":"2024-05-22 13:03","pubTimestamp":1716354210,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["AG","BK4210","LIFE","BK4139","BK4563"],"gpt_icon":0},{"id":"2437857419","title":"Wall Street Breakfast Podcast: U.S Probes ArcelorMittal's Claim Of Patent Violation By Vinfast","url":"https://stock-news.laohu8.com/highlight/detail?id=2437857419","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2437857419?lang=en_us&edition=fundamental","pubTime":"2024-05-21 18:56","pubTimestamp":1716289015,"startTime":"0","endTime":"0","summary":"US launches probe into ArcelorMittal's complaint against VinFast for patent violations.Li Auto postpones launch of all-electric SUVs due to insufficient charging stations and display spots.Microsoft reveals new AI-ready PCs, Surface models, and introduces Recall, a new AI product for Copilot Plus PCs.   HJBC Listen below or on the go on Apple Podcasts and Spotify","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1342641196/image_1342641196.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1342641196/image_1342641196.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4694737-wall-street-breakfast-podcast-us-probes-arcelormittals-claim-of-patent-violation-by-vinfast","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["CMCSA","BK4577","IMAX","MSFT","COIN","INTC","LIFE","VZ","IBM","LU0158827948.USD","PSQ","LU0234572021.USD","MNQmain","LI","RDDT","KRYS","GOSS","DDOG","QID","NQmain","SQ","TQQQ",".IXIC","AMGN","BK4574","IE00B7SZLL34.SGD","ANET","LU0080751232.USD","AMSYF","AAPL","DELL","PANW","MT","LU0786609619.USD","SQQQ","VFS","AMD","QLD","TMUS","LU0234570918.USD","HPQ","LU1162221912.USD","BK4573","MAT","EVS.SI","BK4579","QQQ","QCOM","BK4581"],"gpt_icon":0},{"id":"2436166617","title":"Wall Street Breakfast: The Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2436166617","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2436166617?lang=en_us&edition=fundamental","pubTime":"2024-05-19 18:35","pubTimestamp":1716114940,"startTime":"0","endTime":"0","summary":"Listen on the go!","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1002175840/image_1002175840.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1002175840/image_1002175840.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4694370-wall-street-breakfast-week-ahead","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["LIFE","PANW","NCI","INTU","MSFT","DELL","BAH","INTC","MDT","MRX","NCLH","RBRK","RL","WDAY","ASC","LOAR","LI","TGT","TOL","SNOW","PARA","CHTR","QCOM","LOW","ASUUY","ALB","KRYS","NVDA","AMC","AZO","ZM","TJX","AMGN","ADI","GOSS","BKE","BOW","ELAB","RYI","TD","HUMA","FFIE","KMX","WOOF","CRNC","ETSY","AS","ELF","AUGX","M"],"gpt_icon":0},{"id":"2436186803","title":"Eyes On Nvidia, Microsoft, Wayfair, IBM, And Meme Madness","url":"https://stock-news.laohu8.com/highlight/detail?id=2436186803","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2436186803?lang=en_us&edition=fundamental","pubTime":"2024-05-18 22:30","pubTimestamp":1716042600,"startTime":"0","endTime":"0","summary":"Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4694174-eyes-on-nvidia-microsoft-wayfair-ibm-and-meme-madness","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["NCLH","TOL","RH","ADI","INTC","PARA","TD","RYI","WOOF","CRNC","AMGN","BAH","FFIE","LOW","RBRK","JNJ","LIFE","ELF","BOW","GME","GOSS","MDT","PANW","NVDA","TJX","AUGX","XPEV","ETD","KRYS","BXSL","HUMA","CHTR","YUM","DCI","M","AMC","ASC","AS","LI","INTU","MSFT","NCI","QCOM","ZETA","MU","TSM","DELL","WSM","RL","TGT"],"gpt_icon":1},{"id":"2435582651","title":"SWISS LIFE HOLDING AG :Swiss Life Shareholders Approve All Resolutions Proposed By The Board Of Directors.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435582651","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435582651?lang=en_us&edition=fundamental","pubTime":"2024-05-15 23:02","pubTimestamp":1715785340,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["LIFE","BK4139","BK4563","BK4210","AG"],"gpt_icon":0},{"id":"2435635691","title":"aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2435635691","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435635691?lang=en_us&edition=fundamental","pubTime":"2024-05-15 11:00","pubTimestamp":1715742000,"startTime":"0","endTime":"0","summary":"Findings further demonstrate that NRP2 is an important new immune target in ILD and that efzofitimod modulates myeloid cells to confer anti-inflammatory benefitSAN DIEGO, May  15, 2024  (GLOBE NEWSWIR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882256/0/en/aTyr-Pharma-to-Present-Poster-Describing-Efzofitimod-s-Mechanism-of-Action-at-the-American-Thoracic-Society-2024-International-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","ATS","BK4107","BK4161","AFG","LIFE","BK4139","BK4117"],"gpt_icon":0},{"id":"2435514704","title":"Analysts’ Top Healthcare Picks: aTyr Pharma (LIFE), Dynavax (DVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2435514704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435514704?lang=en_us&edition=fundamental","pubTime":"2024-05-14 22:20","pubTimestamp":1715696408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on aTyr Pharma (LIFE – Research Report) and Dynavax (DV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-atyr-pharma-life-dynavax-dvax?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-atyr-pharma-life-dynavax-dvax?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DV","LIFE","BK4023","BK4539","BK4137","BK4563","DVAX","HCSG"],"gpt_icon":0},{"id":"2435551876","title":"aTyr Pharma Inc :Atyr Pharma Announces Second Positive Dsmb Review For Efzofitimod In Phase 3 Efzo-Fit™ Study In Pulmonary Sarcoidosis.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435551876","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435551876?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:43","pubTimestamp":1715690637,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_live","symbols":["BK4139","LIFE","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.atyrpharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0556},{"period":"1year","weight":0.6239},{"period":"ytd","weight":0.3475}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.022427},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.026924},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.036889},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.052458},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.096577},{"month":6,"riseRate":0.6,"avgChangeRate":-0.014529},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024172},{"month":8,"riseRate":0.111111,"avgChangeRate":-0.082422},{"month":9,"riseRate":0.555556,"avgChangeRate":0.120154},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.07207},{"month":11,"riseRate":0.555556,"avgChangeRate":0.026072},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.077972}],"exchange":"NASDAQ","name":"aTyr Pharma","nameEN":"aTyr Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest aTyr Pharma(LIFE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"aTyr Pharma,LIFE,aTyr Pharma股票,aTyr Pharma股票老虎,aTyr Pharma股票老虎国际,aTyr Pharma行情,aTyr Pharma股票行情,aTyr Pharma股价,aTyr Pharma股市,aTyr Pharma股票价格,aTyr Pharma股票交易,aTyr Pharma股票购买,aTyr Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"aTyr Pharma(LIFE),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest aTyr Pharma(LIFE) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}